CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules)
Mucosal Barrier Repair, GAG Supplementation and Urinary Comfort Support
CYSTIALIZ is an ultra-premium veterinary supplement formulated at the cellular level to protect lower urinary tract health and bladder mucosal barrier in cats and dogs. It is specifically developed to strengthen clinical protocols during idiopathic cystitis (FIC) episodes, recurrent bacterial cystitis, adjuvant needs in struvite diets, and environmental stress-related urinary tract sensitivities. While supporting the reconstruction of the glycosaminoglycan layer lining the urothelium, it rapidly establishes urinary comfort with advanced bioactive ingredients that prevent bacterial adhesion.
Manufactured in Zoopa-licensed GMP and ISO standard facilities with high-purity technology, this innovative formulation balances the inflammatory load in the bladder wall through the synergy of NAG, D-Mannose, A-type proanthocyanidins, and quercetin. It provides evidence-based support that veterinarians can safely prescribe in clinical management by offering superior cellular bioavailability even in the most sensitive metabolic conditions.
Targeted Physiological Axes
The three essential physiological axes targeted and optimized at the cellular level by this formula
Bladder Mucosal Barrier
Rebuilds the thinned GAG layer with NAG and Hyaluronic acid, blocking the irritating effect of urine.
Bacterial Adhesion Prevention
Prevents adhesion and colonization of uropathogenic bacteria to the epithelium via A-type PAC and D-Mannose synergy.
Mast Cell & Inflammation Control
Calms FIC-driven bladder wall mast cell infiltration and oxidative load with quercetin and antioxidant cofactors.
Key Active Botanical & Bio-Actives
Pharmaceutical-grade bio-active constituents and their therapeutic roles
NAG (N-asetil-D-glukozamin)
250 mgMain building block of the glycosaminoglycan (GAG) layer lining the urothelium, reduces mucosal permeability.
Kızılcık Özü (A-tipi PAC)
150 mgPrevents uropathogenic E. coli bacteria from adhering to bladder epithelial cells via P-fimbriae.
D-Mannoz
200 mgBinds to Type 1 fimbriae to prevent bacterial adhesion to the epithelium and ensures mechanical elimination via urine.
Kuersetin
100 mgStabilizes mast cells and suppresses histamine released in the bladder wall during FIC cases.
Hiyalüronik Asit
50 mgSupports the integrity of the GAG layer, forming a protective barrier against the irritating effects of urine.
Clinical & Biochemical Rationale
CYSTIALIZ is engineered to target the complex pathophysiology of lower urinary tract disorders in companion animals through a multi-modal pharmacological approach. In feline idiopathic cystitis (FIC) and canine bacterial cystitis, the urothelial glycosaminoglycan (GAG) layer experiences thinning and increased permeability, exposing submucosal tissues to irritating urinary solutes. The inclusion of NAG and Hyaluronic Acid provides the essential monosaccharide precursors and structural polymers required for rapid mucosal barrier restoration. Simultaneously, A-type proanthocyanidins from Cranberry extract and D-Mannose competitively bind to bacterial adhesins (P-fimbriae and Type 1 fimbriae), neutralizing uropathogenic E. coli colonization without disrupting systemic microbiota. Quercetin acts as a potent mast cell stabilizer, mitigating neurogenic inflammation and histamine release within the bladder wall. Supported by liposomal glutathione, zinc, and selenium, this formulation neutralizes oxidative stress, optimizes urothelial healing, and ensures long-term clinical remission.
Veterinary Administration Standard
Recommended Dosage & Administration Protocol
View Protocol
Hide
Recommended Dosage & Administration Protocol
- 01 Administer orally directly into the mouth or open the twist-off capsule and mix its contents with daily food according to body weight. For cats and dogs up to 10 kg: 1 capsule per day. For pets between 10-20 kg: 2 capsules per day. For pets over 20 kg: 3 capsules per day. Use for an initial period of 4 to 6 weeks or as recommended by your veterinarian for chronic maintenance.
Frequently Asked Questions
Essential clinical questions on formula kinetics, tolerance, and administration
How does CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules) reduce nephron workload in chronic kidney disease patients?
CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules) binds enteric phosphorus and uremic waste, preventing systemic reabsorption and alleviating hyperfiltration stress on remaining functional nephrons.
When can stabilization in serum BUN, Creatinine, and SDMA levels be expected?
Clinical stabilization in serum uremic markers is officially verified through follow-up biochemistry panels at day 30 and day 60 of continuous therapy.
Can CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules) be administered alongside renal prescription diets and ACE inhibitors?
Yes, it exhibits complete synergistic compatibility with veterinary-prescribed renal diets and cardiovascular medications without pharmacokinetic competition.
Should CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules) be given on an empty stomach or with meals?
To maximize phosphate-binding efficacy in the intestinal lumen, administration with meals or blended directly into daily food is clinically recommended.
How does CYSTIALIZ Canine & Feline Bladder and Urinary Tract Support Twist-Off Capsules (60 Twist-Off Capsules) address uremic inappetence and weight loss?
By mitigating circulating uremic waste, it relieves uremic gastritis and nausea, supporting spontaneous appetite and lean body mass retention.
Where can you obtain Chosen Family formulas?
Our formulations are distributed exclusively through authorized veterinary hospitals and clinical practices to accompany veterinary care.
